Clinical Proteomic Tumor Analysis January 24, 2022 By mloggins HTSF supported Clinical Proteomic Tumor Analysis Consortium by providing microRNA sequencing. Filed Under: Categories: What's New More from High-Throughput Sequencing Facility (HTSF) Introducing the DNBSEQ-T7: Advancing Genomic Research Through Innovative Sequencing Novaseq 6000 and Nextseq2000 vs HiSeq4000, mRNA comparison Scientific Highlights-Allogeneic Hematopoietic Stem Cell Transplantation